美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
62542-301-17	62542-301	HUMAN PRESCRIPTION DRUG	Hydrocodone Polistirex and Chlorpheniramine Polistirex	Hydrocodone Polistirex and Chlorpheniramine Polistirex	SUSPENSION, EXTENDED RELEASE	ORAL	20141023	20240531	ANDA	ANDA091671	Neos Therapeutics LP	CHLORPHENIRAMINE; HYDROCODONE	8 mg/5mL; 10 mg/5mL	473 mL in 1 BOTTLE, GLASS (62542-301-17)
62542-301-16	62542-301	HUMAN PRESCRIPTION DRUG	Hydrocodone Polistirex and Chlorpheniramine Polistirex	Hydrocodone Polistirex and Chlorpheniramine Polistirex	SUSPENSION, EXTENDED RELEASE	ORAL	20141023	20240531	ANDA	ANDA091671	Neos Therapeutics LP	CHLORPHENIRAMINE; HYDROCODONE	8 mg/5mL; 10 mg/5mL	473 mL in 1 BOTTLE, GLASS (62542-301-16)
62542-301-04	62542-301	HUMAN PRESCRIPTION DRUG	Hydrocodone Polistirex and Chlorpheniramine Polistirex	Hydrocodone Polistirex and Chlorpheniramine Polistirex	SUSPENSION, EXTENDED RELEASE	ORAL	20141023	20240531	ANDA	ANDA091671	Neos Therapeutics LP	CHLORPHENIRAMINE; HYDROCODONE	8 mg/5mL; 10 mg/5mL	118 mL in 1 BOTTLE, GLASS (62542-301-04)
62542-301-03	62542-301	HUMAN PRESCRIPTION DRUG	Hydrocodone Polistirex and Chlorpheniramine Polistirex	Hydrocodone Polistirex and Chlorpheniramine Polistirex	SUSPENSION, EXTENDED RELEASE	ORAL	20191105	20240531	ANDA	ANDA091671	Neos Therapeutics LP	CHLORPHENIRAMINE; HYDROCODONE	8 mg/5mL; 10 mg/5mL	70 mL in 1 BOTTLE, GLASS (62542-301-03)